A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia

by | Jul 8, 2026 | Clinical Trials | 0 comments

​ Conditions: Iron Deficiency Anemia (IDA)

Interventions: Drug: Ferric Bepectate IV Injection; Drug: Ferric Carboxymaltose Injection [Ferinject]; Drug: Ferric Carboxymaltose Injection [Injectafer®]

Sponsors: AFT Pharmaceuticals, Ltd.; HungaroTrial

Not yet recruiting Conditions: Iron Deficiency Anemia (IDA)
Interventions: Drug: Ferric Bepectate IV Injection; Drug: Ferric Carboxymaltose Injection [Ferinject]; Drug: Ferric Carboxymaltose Injection [Injectafer®]
Sponsors: AFT Pharmaceuticals, Ltd.; HungaroTrial
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *